Retractable Technologies RVP
NYSE RVP
$0.71 -0.01 (-0.78%)
As of: Sep 10, 2026 · 12:06 PM EDT

Retractable Technologies (RVP) Total Non-Current Liabilities (2018 - 2026)

Retractable Technologies' (RVP) quarterly Total Non-Current Liabilities came in at $13.7 million in Q2 2026, up 41.19% on a YoY basis from $9.7 million in Q2 2025, and up 25.94% quarter-over-quarter from $10.9 million in Q1 2026.

Analysis

Retractable Technologies (RVP) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

Retractable Technologies (RVP) has reported Total Non-Current Liabilities for 9 consecutive years, with $13.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Non-Current Liabilities rose 41.19% year-over-year to $13.7 million; the trailing twelve-month figure through Jun 2026 stood at $13.7 million (up 41.19% YoY), and the FY2025 full-year result was $10.1 million, up 4.62% from the prior year.
  • Total Non-Current Liabilities rose to $13.7 million in Q2 2026 per RVP's latest filing, from $10.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $30.2 million in Q1 2022 and bottomed at $8.0 million in Q1 2024.
  • Historically, Total Non-Current Liabilities has averaged $12.3 million across 5 years, with a median of $10.4 million in 2023.
  • The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities plunged 63.88% in 2022, then surged 41.19% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $13.7 million in 2022, then retreated by 22.37% to $10.6 million in 2023, then slipped by 8.77% to $9.7 million in 2024, then climbed by 4.62% to $10.1 million in 2025, then jumped by 35.29% to $13.7 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $13.7 million, $10.9 million, and $10.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Becton Dickinson 48.41 Bn 47.55 Bn 2.32 Bn 23.92 Bn
2 Medline 27.78 Bn 25.10 Bn 2.22 Bn 17.56 Bn
3 West Pharmaceutical Services 24.42 Bn 23.98 Bn 329.20 Mn 996.30 Mn
4 Baxter International 12.49 Bn 10.34 Bn 1.03 Bn 12.41 Bn
5 Stevanato Group S.p.A 5.70 Bn 5.59 Bn 100.91 Mn -89.27 Mn
6 Acme United 235.29 Mn 230.25 Mn 26.69 Mn 75.19 Mn
7 Rockwell Medical 31.39 Mn 6.60 Mn 3.24 Mn -
8 Retractable Technologies 21.15 Mn -18.72 Mn 190,852.00 13.70 Mn
9 United Health Products 8.85 Mn 8.82 Mn - 4.54 Mn
10 Cuprina Holdings (Cayman) 7.88 Mn 4.76 Mn - 333,758.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.70 Mn
Mar 31, 2026 10.88 Mn
Dec 31, 2025 10.13 Mn
Sep 30, 2025 10.25 Mn
Jun 30, 2025 9.70 Mn
Mar 31, 2025 10.31 Mn
Dec 31, 2024 9.68 Mn
Sep 30, 2024 9.01 Mn
Jun 30, 2024 8.49 Mn
Mar 31, 2024 8.03 Mn
Dec 31, 2023 10.61 Mn
Sep 30, 2023 10.57 Mn
Jun 30, 2023 10.26 Mn
Mar 31, 2023 11.75 Mn
Dec 31, 2022 13.67 Mn
Sep 30, 2022 16.59 Mn
Jun 30, 2022 17.91 Mn
Mar 31, 2022 30.17 Mn
Dec 31, 2021 37.14 Mn
Sep 30, 2021 38.09 Mn